Ihe dị ọcha na-emegide ọrịa cancer dị elu CAS 114977-28-5 Docetaxel

Nkọwa dị mkpirikpi:

Docetaxel bụ API semi-synthetic, yana ọgbọ nke abụọ mgbochi kansa API nwetara site na ọkara njikọ nke 10-DAB.Docetaxel bụ ọgwụ taxedịkị nke ọkara.Ọmụmụ ọgwụ na-agwọ ọrịa ekwenyela na ọrụ antitumor nke docetaxel siri ike karịa nke paclitaxel, ọ dịghịkwa ihe mgbochi na paclitaxel.Hande Bio na-enye akụrụngwa akụrụngwa mgbochi ọrịa kansa dị elu CAS 114977-28-5 Docetaxel.Maka nkọwa ndị ọzọ, biko kpọtụrụ anyị n'ịntanetị.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Docetaxel

Nọmba CAS:114977-28-5

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Ọrụ

Maka ọgwụgwọ ọrịa kansa ara dị elu, ọrịa kansa akpa ume na-abụghị obere cell.A na-ejikwa ya na-agwọ etuto dị ka ọrịa kansa isi na olu, ọrịa cancer akpa ume obere cell, ọrịa kansa afọ, na ọrịa cancer ovarian.

Dị ka paclitaxel, ọ na-enwe mmetụta dị mma na ọrịa cancer akpa ume na-abụghị obere cell na ọrịa ara ara, a pụkwara iji ya mee ihe maka ọrịa isi na olu na ọrịa cancer ovarian.

Mpaghara ngwa

Ụlọ ọrụ ọgwụ

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.

Ike nke Hande

Hande nwere otu R&D ruo ọtụtụ afọ.Ndị otu ahụ etinyela akwụkwọ maka ọtụtụ ihe achọpụtara ikike, na usoro ahụ enweghị nkebi site na ụlọ nyocha ruo na mmepụta nnukwu azụmahịa.Isi ihe nrụpụta GMP wuru onwe ya agafeela nyocha usoro iwu nke US FDA, EU EDQM, China GMP, Japan PMDA, Australia TGA, South Korea, India, China Taiwan, Turkey, Russia, SGS, Dun & Bradstreet na ụkpụrụ ndị ọzọ.N'otu oge ahụ, ụlọ ọrụ ahụ na-eji otu nyocha na mmepe mmepe, wee nweta ọtụtụ akwụkwọ ikike.QC ule ụlọ, ukwuu ghọta ngwaahịa ihe ule.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: